Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Journal of Glaucoma
|
January 17, 2007
Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy
Richard A Lewis, Gregory J Katz, Mark J Weiss, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
|
February 22, 2008
Efficacy of brinzolamide and levobetaxolol in pediatric glaucomas: a randomized clinical trial
Jess T Whitson, John D Roarty, Lingam Vijaya, et al.
The New England Journal of Medicine
|
September 29, 2021
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
William J Sandborn, Brian G Feagan, Geert D'Haens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2013
Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximab
Luis Fayad, Fritz Offner, Mitchell R Smith, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Journal of Glaucoma
|
January 17, 2007
Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy
Richard A Lewis, Gregory J Katz, Mark J Weiss, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
|
February 22, 2008
Efficacy of brinzolamide and levobetaxolol in pediatric glaucomas: a randomized clinical trial
Jess T Whitson, John D Roarty, Lingam Vijaya, et al.
The New England Journal of Medicine
|
September 29, 2021
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
William J Sandborn, Brian G Feagan, Geert D'Haens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2013
Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximab
Luis Fayad, Fritz Offner, Mitchell R Smith, et al.
Page
of 2